text.skipToContent text.skipToNavigation

This site is optimized for Chrome, Edge, Firefox, and Safari. You may not have the best user experience in your current browser.

D-Stat® Dry® Topical Hemostat
Packaging 10 / BX

Product review summary

Representative image. Actual product may vary.

View All Additional Items
Dressing Type
Pad Count
Dressing Material
Please see the Instructions for Use for a complete listing of the indications, contraindications, warnings, and precautions.

Item Description

D-Stat® Dry® Topical Hemostat

The D-Stat® Dry® is applied topically as an adjunct to manual compression and is indicated for the control of surface bleeding from vascular access sites and percutaneous catheters or tubes and reducing the time-to-hemostasis in patients undergoing diagnostic endovascular procedures utilizing 4-6 Fr. introducer sheaths.

- THROMBIN-JMI® can cause fatal severe bleeding or thrombosis. Thrombosis may result from the development of antibodies against bovine thrombin. Bleeding may result from the development of antibodies against factor V. These may cross-react with human factor V and lead to its deficiency.
- Do not re-expose patients to THROMBIN-JMI® if there are known or suspected antibodies to bovine thrombin and/or factor V.
- Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.

MC-007695 - Rev 1. Revised: 03/2022.

D-Stat® Dry Topical Hemostat
3000D-Stat® Dry Silver Topical Hemostat
3005D-Stat® Dry Clear Silver Topical Hemostat
3001D-Stat® Dry Topical Hemostat
3006D-Stat® Dry Clear Topical Hemostat
3010D-Stat® 2 Dry Topical Hemostat